Yoram Devary
Chairman
Claimed by owner TwoToBiotech
Former names:
Novel Human Peptide Hormones to Treat Diabetes
TwoToBiotech
About
TwoToBiotech's researchers have identified a novel human peptide hormone (P3) thatis expressed in activated immune cells. The company subsequently developed a platform technology with several specific monoclonal antibodies against P3 in order to treat autoimmune diseases.
In-vivo studies show that the antibody may be effectivefor treatment of type 1 and type 2 diabetes.
TwoToBiotech is developing another novel human peptide hormone, APC1, for treatment of type 2 diabetes. Initial tests on mice have shown promise. The company has also isolated a novel human cardiac peptide that may have the potential tostrongly regulate glucose metabolism.
In-vivo studies show that the antibody may be effectivefor treatment of type 1 and type 2 diabetes.
TwoToBiotech is developing another novel human peptide hormone, APC1, for treatment of type 2 diabetes. Initial tests on mice have shown promise. The company has also isolated a novel human cardiac peptide that may have the potential tostrongly regulate glucose metabolism.
Primary Sector
Life Sciences & HealthTech
Products
-
Geographic markets
United States
News
(0)The Team
(4)
YD
OD
Orly Devary
Co-founder & CEO
TS
Tamara Sandler
Co-founder & Chief Scientist
PUS
Prof. Uziel Sandler
Director
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Pre-Seed
$500K
Jul 2020
1 Investors
$500K
Media gallery
(1)
Novel Biological Molecules at Work
Locations
Israel
Rosenblatt 7, Jerusalem, Israel
Locations
Israel
Rosenblatt 7, Jerusalem, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,